outperform

Great results. Out of charts really.
French trials seem so well constructed as to have ferreted out the compound's distinguishing features.

Notwithstanding a peddly EEG monitor as "correlation" to brain activity, placebos kindly sluggish anxiety recovery is a bonenza.

No reprorted side effects this time round. Woo hoo.

Groovy team. We look forward to detail reports, as they flow in timely fashion, above par.

And to top it off a vascular disrupting agent trial reporting from US later on.

Who would want to part this company from its geniuses? Did we say take over? JV?